Allelic loss at the GPx-1 locus in cancer of the head and neck

Biological Trace Element Research

Volumn 101, Issue 2, 2004, Pages 97-106

  Hu, Ya Jun ^a   Dolan, M Eileen ^b   Bae, Richard ^c   Yee, Herman ^d   Roy, Martin ^c   Glickman, Robert ^c   Kiremidjian Schumacher, Lidia ^c   Diamond, Alan M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Glutathione peroxidase; Head and neck cancer; Loss of heterozygosity; Polymorphism; Selenium; Selenoprotein

Indexed keywords

DNA; GLUTATHIONE PEROXIDASE;

ADULT; AGED; ALLELE; AMINO ACID SEQUENCE; ARTICLE; CANCER RISK; CARCINOGENESIS; CODON; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC POLYMORPHISM; GENOTYPE; HEAD CANCER; HETEROZYGOSITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LYMPHOCYTE; MALE; NECK CANCER; SQUAMOUS CELL CARCINOMA;

EID: 9644266978     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/bter:101:2:097     Document Type: Article

References (15)

1. M. P. Tabor, R. H. Brakenhoff, V. M. van Houten, et al., Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications, Clin. Cancer Res. 7, 1523-1532 (2001).
2. B. J. Braakhuis, M. P. Tabor, J. A. Kummer, C. R. Leemans, and R. H. Brakenhoff, A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications, Cancer Res. 63, 1727-1730 (2003).
3. S. B. Garcia, H. S. Park, M. Novelli, and N. A. Wright,. Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets, J. Pathol. 137, 61-81 (1999).
4. J. Califano, P. van der Riet, W. Westra, et al., Genetic progression model for head and neck cancer: implications for field cancerization, Cancer Res. 56, 2488-2492 (1996).
5. J. A. Moscow, L. Schmidt, D. T. Ingram, J. Gnarra, B. Johnson, and K. H. Cowan, Loss of heterozygosity of the human cytosolic glutathione peroxidase I gene in lung cancer, Carcinogenesis 15, 2769-2773 (1994).
6. Y. J. Hu and A. M. Diamond, Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium, Cancer Res. 63, 3347-3351 (2003).
7. D. Ratnasinghe, J. A. Tangrea, M. R. Andersen, et al., Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk, Cancer Res. 60, 6381-6383 (2000).
8. K. El-Bayoumy, The Role of Selenium in Cancer Prevention, Lippincott, Philadelphia, pp. 1-15 (1991).
9. W. J. Goodwin, Jr., G. D. Bordash, F. Huijing, and N. Altman, Inhibition of hamster tongue carcinogenesis by selenium and retinoic acid, Ann. Otol. Rhinol. Laryngol. 95, 162-166 (1986).
10. I. Inoue, Y. Yamamoto, T. Takasaki, and H. Takahashi, Inhibitory effects of selenium, vitamin A and butylated hydroxytoluene on in vitro growth of human tongue cancer cells, Eur. Arch. Otorhinolaryngol. 252, 509-512 (1995).
11. A. Ghose, J. Fleming, K. El-Bayoumy, and P. R. Harrison. Enhanced sensitivity of human oral carcinomas to induction of apoptosis by selenium compounds: involvement of mitogen-activated protein kinase and Fas pathways, Cancer Res. 61, 7479-7487 (2001).
12. L. Kiremidjian-Schumacher, M. Roy, R. Lickman, et al., Selenium and immunocompetence in patients with head and neck cancer, Biol. Trace Element Res. 73, 97-111 (2000).
13. Y. J. Hu, K. V. Korotkov, R. Mehta, et al., Distribution and functional consequences of nucleotide polymorphisms in the 3′-untranslated region of the human Sep15 gene, Cancer Res. 61, 2307-2310 (2001).
14. L. C. Clark, G. F. J. Combs, B. W. Turnbull, et al., Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial, J. Am. Med. Assoc. 276, 1957-1963 (1996).
15. S. Y Yu, Y. J. Zhu, and W. G. Li, Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong, Biol. Trace Element Res. 56, 117-124 (1997).